Atrial Fibrillation Ablation: Indications, Emerging Techniques, and Follow-Up

Progress in Cardiovascular Diseases

Volumn 58, Issue 2, 2015, Pages 202-212

  Gerstenfeld, Edward P ^a   Duggirala, Srikant ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atrial fibrillation; Catheter ablation; Cryoablation; Laser; Pulmonary vein

Indexed keywords

ABLATION CATHETER; ARTICLE; ATRIAL FIBRILLATION; BALLOON CATHETER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVERSION; CATHETER ABLATION; CLINICAL EFFECTIVENESS; CRYOABLATION; CRYOBALLOON CATHETER; ELECTROCARDIOGRAPHY MONITORING; HEART FAILURE; HOLTER MONITORING; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PAROXYSMAL ATRIAL FIBRILLATION; PATIENT SELECTION; PERSISTENT ATRIAL FIBRILLATION; PULMONARY VEIN ISOLATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINUS RHYTHM; TELEMETRY; TREATMENT INDICATION; WEIGHT REDUCTION; ADVERSE EFFECTS; COMORBIDITY; ELECTROCARDIOGRAPHY; HEART MUSCLE CONDUCTION SYSTEM; HEART RATE; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES; PULMONARY VEIN; RISK FACTOR; TREATMENT OUTCOME;

ATRIAL FIBRILLATION; CATHETER ABLATION; COMORBIDITY; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART RATE; HUMANS; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PULMONARY VEINS; RISK FACTORS; TREATMENT OUTCOME;

EID: 84942099824     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2015.07.008     Document Type: Article

References (100)

1. Miyasaka Y., Barnes M.E., Gersh B.J., et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006, 114(2):119-125.
2. Go A.S., Hylek E.M., Phillips K.A., et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001, 285(18):2370-2375.
3. Scherf D., Romano F.J., Terranova R. Experimental studies on auricular flutter and auricular fibrillation. Am Heart J 1948, 36(2):241-251.
4. Moe G.K., Abildskov J.A. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge. Am Heart J 1959, 58(1):59-70.
5. Moe G.K., Rheinboldt W.C., Abildskov J.A. A computer model of atrial fibrillation. Am Heart J 1964, 67:200-220.
6. Moe G. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962, 140:183-188.
7. Wijffels M.C., Kirchhof C.J., Dorland R., et al. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995, 92(7):1954-1968.
8. Wijffels M.C., Kirchhof C.J., Dorland R., et al. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 1997, 96(10):3710-3720.
9. Allessie M.A., Konings K., Kirchhof C.J., et al. Electrophysiologic mechanisms of perpetuation of atrial fibrillation. Am J Cardiol 1996, 77(3):10A-23A.
10. Jalife J., Berenfeld O., Skanes A., et al. Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both?. J Cardiovasc Electrophysiol 1998, 9(8 Suppl.):S2-S12.
11. Mandapati R., Skanes A., Chen J., et al. Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart. Circulation 2000, 101(2):194-199.
12. Skanes A.C., Mandapati R., Berenfeld O., et al. Spatiotemporal periodicity during atrial fibrillation in the isolated sheep heart. Circulation 1998, 98(12):1236-1248.
13. Haïssaguerre M., Jaïs P., Shah D.C., et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998, 339(10):659-666.
14. Calkins H., Kuck K.H., Cappato R., et al. 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Europace 2012, 14(4):528-606.
15. January C.T., Wann L.S., Alpert J.S., et al. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014, 64(21):e1-e76.
16. Wazni O.M., Marrouche N.F., Martin D.O., et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005, 293(21):2634-2640.
17. Cosedis Nielsen J., Johannessen A., Raatikainen P., et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med 2012, 367(17):1587-1595.
18. Morillo C.A., Verma A., Connolly S.J., et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA 2014, 311(7):692-700.
19. Gentlesk P.J., Sauer W.H., Gerstenfeld E.P., et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2007, 18(1):9-14.
20. Hsu L.F., Jaïs P., Sanders P., et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004, 351(23):2373-2383.
21. Khan M.N., Jaïs P., Cummings J., et al. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008, 359(17):1778-1785.
22. Mathew J.P., Fontes M.L., Tudor I.C., et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004, 291(14):1720-1729.
23. Rathore S.S., Berger A.K., Weinfurt K.P., et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 2000, 101(9):969-974.
24. Benjamin E.J., Levy D., Vaziri S.M., D'Agostino R.B., Belanger A.J., Wolf P.A. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994, 271(11):840-844.
25. Waldo A.L., Feld G.K. Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications. J Am Coll Cardiol 2008, 51(8):779-786.
26. Oakes R.S., Badger T.J., Kholmovski E.G., et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009, 119(13):1758-1767.
27. Kuppahally S.S., Akoum N., Burgon N.S., et al. Left atrial strain and strain rate in patients with paroxysmal and persistent atrial fibrillation: relationship to left atrial structural remodeling detected by delayed-enhancement MRI. Circ Cardiovasc Imaging 2010, 3(3):231-239.
28. Marrouche N.F., Wilber D., Hindricks G., et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA 2014, 311(5):498-506.
29. Pathak R.K., Middeldorp M.E., Lau D.H., et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation. J Am Coll Cardiol 2014, 64(21):2222-2231.
30. Bartus K., Han F.T., Bednarek J., et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol 2013, 62(2):108-118.
31. Reddy V.Y., Holmes D., Doshi S.K., Neuzil P., Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation 2011, 123:417-424.
32. Jaïs P., Haïssaguerre M., Shah D.C., et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 1997, 95(3):572-576.
33. Karch M.R., Zrenner B., Deisenhofer I., et al. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 2005, 111(22):2875-2880.
34. Gerstenfeld E.P., Dixit S., Callans D., et al. Utility of exit block for identifying electrical isolation of the pulmonary veins. J Cardiovasc Electrophysiol 2002, 13(10):971-979.
35. Tamborero D., Mont L., Berruezo A., et al. Circumferential pulmonary vein ablation: does use of a circular mapping catheter improve results? A prospective randomized study. Heart Rhythm 2010, 7(5):612-618.
36. McLellan A.J.A., Kumar S., Smith C., Morton J.B., Kalman J.M., Kistler P.M. The role of adenosine following pulmonary vein isolation in patients undergoing catheter ablation for atrial fibrillation: a systematic review. J Cardiovasc Electrophysiol 2013, 24(7):742-751.
37. Macle L., Khairy P., Weerasooriya R.A., et al. Adenosine-guided pulmonary vein isolation for the treatment of atrial fibrillation: results of the prospective multicenter randomized ADVICE trial. Late Breaking Clinical Trials, Heart Rhythm 2014 Conference, San Francisco, CA 2014.
38. Cappato R., Calkins H., Chen S.A., et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010, 3(1):32-38.
39. Brooks A.G., Stiles M.K., Laborderie J., et al. Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 2010, 7(6):835-846.
40. Mont L., Bisbal F., Hernández-Madrid A., et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study). Eur Heart J 2014, 35(8):501-507.
41. Hocini M., Jaïs P., Sanders P., et al. Techniques, evaluation, and consequences of linear block at the left atrial roof in paroxysmal atrial fibrillation: a prospective randomized study. Circulation 2005, 112(24):3688-3696.
42. Jaïs P., Hocini M., Hsu L.F., et al. Technique and results of linear ablation at the mitral isthmus. Circulation 2004, 110(19):2996-3002.
43. Sawhney N., Anousheh R., Chen W., et al. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2010, 3(3):243-248.
44. Anousheh R., Sawhney N.S., Panutich M., et al. Effect of mitral isthmus block on development of atrial tachycardia following ablation for atrial fibrillation. Pacing Clin Electrophysiol 2010, 33(4):460-468.
45. Tamborero D., Mont L., Berruezo A., et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study. Circ Arrhythm Electrophysiol 2009, 2(1):35-40.
46. Verma A., Jiang C., Betts T.R., et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015, 372(19):1812-1822.
47. Lo L.W., Tai C.T., Lin Y.J., et al. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. Heart Rhythm 2009, 6(3):311-318.
48. Lin W.S., Tai C.T., Hsieh M.H., et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation 2003, 107(25):3176-3183.
49. Lin D., Frankel D.S., Zado E.S., et al. Pulmonary vein antral isolation and nonpulmonary vein trigger ablation without additional substrate modification for treating longstanding persistent atrial fibrillation. J Cardiovasc Electrophysiol 2012, 23(8):806-813.
50. Pauza D.H., Skripka V., Pauziene N., et al. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec 2000, 259:353-382.
51. Armour J.A., Collier K., Kember G., et al. Differential selectivity of cardiac neurons in separate intrathoracic autonomic ganglia. Am J Physiol 1998, 274:R939-R949.
52. Patterson E., Po S.S., Scherlag B.J., et al. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm 2005, 2(6):624-631.
53. Pokushalov E., Turov A., Shugayev P., et al. Catheter ablation of left atrial ganglionated plexi for atrial fibrillation. Asian Cardiovasc Thorac Ann 2008, 16(3):194-201.
54. Lemery R., Birnie D., Tang A.S.L., et al. Feasibility study of endocardial mapping of ganglionated plexuses during catheter ablation of atrial fibrillation. Heart Rhythm 2006, 3(4):387-396.
55. Pokushalov E., Romanov A., Artyomenko S., et al. Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol 2010, 33(10):1231-1238.
56. Pokushalov E., Romanov A., Shugayev P., et al. Selective ganglionated plexi ablation for paroxysmal atrial fibrillation. Heart Rhythm 2009, 6(9):1257-1264.
57. Pokushalov E., Romanov A., Artyomenko S., et al. Ganglionated plexi ablation for longstanding persistent atrial fibrillation. Europace 2010, 12(3):342-346.
58. Takahashi Y., Sanders P., Rotter M., et al. Disconnection of the left atrial appendage for elimination of foci maintaining atrial fibrillation. J Cardiovasc Electrophysiol 2005, 16(8):917-919.
59. Di Biase L., Burkhardt J.D., Mohanty P., et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation 2010, 122(2):109-118.
60. Chan C.P., Wong W.S., Pumprueg S., et al. Inadvertent electrical isolation of the left atrial appendage during catheter ablation of persistent atrial fibrillation. Heart Rhythm 2010, 7(2):173-180.
61. Pison L., La Meir M., van Opstal J., et al. Hybrid thoracoscopic surgical and transvenous catheter ablation of atrial fibrillation. J Am Coll Cardiol 2012, 60(1):54-61.
62. Calkins H. Hybrid thoracoscopic and transvenous catheter ablation of atrial fibrillation: is this the answer we are searching for?. J Am Coll Cardiol 2012, 60(1):62-63.
63. Bisleri G., Rosati F., Bontempi L., et al. Hybrid approach for the treatment of long-standing persistent atrial fibrillation: electrophysiological findings and clinical results. Eur J Cardiothorac Surg 2013, 44(5):919-923.
64. Wazni O., Marrouche N.F., Martin D.O., et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation 2003, 108(20):2479-2483.
65. Pokushalov E., Romanov A., Corbucci G., et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 2012, 60(13):1163-1170.
66. Jaïs P., Haïssaguerre M., Shah D.C., et al. Successful irrigated-tip catheter ablation of atrial flutter resistant to conventional radiofrequency ablation. Circulation 1998, 98(9):835-838.
67. Natale A., Reddy V.Y., Monir G., et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol 2014, 64(7):647-656.
68. Reddy V.Y., Shah D., Kautzner J., et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Hear Rhythm 2012, 9(11):1789-1795.
69. Neuzil P., Reddy V.Y., Kautzner J., et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol 2013, 6(2):327-333.
70. Kautzner J., Neuzil P., Lambert H., et al. EFFICAS II: optimization of catheter contact force improves outcome of pulmonary vein isolation for paroxysmal atrial fibrillation. Europace 2015, 17(8):1229-1235.
71. Packer D.L., Kowal R.C., Wheelan K.R., et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol 2013, 61(16):1713-1723.
72. Fürnkranz A., Bordignon S., Schmidt B., et al. Improved procedural efficacy of pulmonary vein isolation using the novel second-generation cryoballoon. J Cardiovasc Electrophysiol 2013, 24(5):492-497.
73. Aryana A., Morkoch S., Bailey S., et al. Acute procedural and cryoballoon characteristics from cryoablation of atrial fibrillation using the first- and second-generation cryoballoon: a retrospective comparative study with follow-up outcomes. J Interv Card Electrophysiol 2014, 41(2):177-186.
74. Squara F., Zhao A., Marijon E., et al. Comparison between radiofrequency with contact force-sensing and second-generation cryoballoon for paroxysmal atrial fibrillation catheter ablation: a multicentre European evaluation. Europace 2015, 17(5):718-724.
75. Metzner A., Rausch P., Lemes C., et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28mm cryoballoon. J Cardiovasc Electrophysiol 2014, 25(5):466-470.
76. Lakhani M., Saiful F., Bekheit S., Kowalski M. Use of intracardiac echocardiography for early detection of phrenic nerve injury during cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol 2012, 23(8):874-876.
77. Franceschi F., Dubuc M., Guerra P.G., et al. Diaphragmatic electromyography during cryoballoon ablation: a novel concept in the prevention of phrenic nerve palsy. Heart Rhythm 2011, 8(6):885-891.
78. Lakhani M., Saiful F., Parikh V., et al. Recordings of diaphragmatic electromyograms during cryoballoon ablation for atrial fibrillation accurately predict phrenic nerve injury. Heart Rhythm 2014, 11(3):369-374.
79. Šedivá L., Petrů J., Škoda J., et al. Visually guided laser ablation: a single-centre long-term experience. Europace 2014, 16(12):1746-1751.
80. Dukkipati S.R., Woollett I., McElderry H.T., et al. Pulmonary vein isolation using the visually-guided laser balloon: results of the US feasibility study. J Cardiovasc Electrophysiol 2015, http://10.1111/jce.12727[Epub ahead of print].
81. Reddy V., Dukkipati S., Cuoco F., et al. Visually-guided laser balloon (VGLB) pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation (PAF): results of the prospective multicenter randomized Heartlight study. Late Breaking Clinical Trials, Heart Rhythm 2015 Conference, Boston MA 2015.
82. Beukema R.P., Beukema W.P., Smit J.J., et al. Efficacy of multi-electrode duty-cycled radiofrequency ablation for pulmonary vein disconnection in patients with paroxysmal and persistent atrial fibrillation. Europace 2010, 12(4):502-507.
83. Scharf C., Boersma L., Davies W., et al. Ablation of persistent atrial fibrillation using multielectrode catheters and duty-cycled radiofrequency energy. J Am Coll Cardiol 2009, 54(15):1450-1456.
84. Gaita F., Leclercq J.F., Schumacher B., et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol 2011, 22(9):961-968.
85. Herrera Siklódy C., Deneke T., Hocini M., et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol 2011, 58(7):681-688.
86. Zellerhoff S., Daly M., Lim H.S., et al. Pulmonary vein isolation using a circular, open irrigated mapping and ablation catheter (nMARQ): a report on feasibility and efficacy. Europace 2014, 16(9):1296-1303.
87. Thomas D., Scholz E.P., Schweizer P.A., et al. Initial experience with robotic navigation for catheter ablation of paroxysmal and persistent atrial fibrillation. J Electrocardiol 2012, 45(2):95-101.
88. Bai R., Di Biase L., Valderrabano M., et al. Worldwide experience with the robotic navigation system in catheter ablation of atrial fibrillation: methodology, efficacy and safety. J Cardiovasc Electrophysiol 2012, 23(8):820-826.
89. Pappone C., Vicedomini G., Manguso F., et al. Robotic magnetic navigation for atrial fibrillation ablation. J Am Coll Cardiol 2006, 47(7):1390-1400.
90. Bertaglia E., Stabile G., Senatore G., et al. Predictive value of early atrial tachyarrhythmias recurrence after circumferential anatomical pulmonary vein ablation. Pacing Clin Electrophysiol 2005, 28(5):366-371.
91. Vasamreddy C.R., Lickfett L., Jayam V.K., et al. Predictors of recurrence following catheter ablation of atrial fibrillation using an irrigated-tip ablation catheter. J Cardiovasc Electrophysiol 2004, 15(6):692-697.
92. Arya A., Hindricks G., Sommer P., et al. Long-term results and the predictors of outcome of catheter ablation of atrial fibrillation using steerable sheath catheter navigation after single procedure in 674 patients. Europace 2010, 12(2):173-180.
93. Roux J.F., Zado E., Callans D.J., et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study). Circulation 2009, 120(12):1036-1040.
94. Leong-Sit P., Roux J.F., Zado E., et al. Antiarrhythmics after ablation of atrial fibrillation (5A Study): six-month follow-up study. Circ Arrhythm Electrophysiol 2011, 4(1):11-14.
95. Hindricks G., Piorkowski C., Tanner H., et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005, 112(3):307-313.
96. Themistoclakis S., Corrado A., Marchlinski F.E., et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 2010, 55(8):735-743. [Internet, cited 2015 May 21, Available from: http://content.onlinejacc.org/article.aspx?articleid=1140481].
97. Ziegler P.D., Koehler J.L., Mehra R. Comparison of continuous versus intermittent monitoring of atrial arrhythmias. Heart Rhythm 2006, 3(12):1445-1452.
98. Hindricks G., Pokushalov E., Urban L., et al. Performance of a new leadless implantable cardiac monitor in detecting and quantifying atrial fibrillation: results of the XPECT trial. Circ Arrhythm Electrophysiol 2010, 3(2):141-147.
99. Stepanyan G., Badhwar N., Lee R.J., et al. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol 2014, 40(1):33-38.
100. Phan K., Wang N., Pison L., et al. Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: a meta-analysis. Int J Cardiol 2015, 185:209-213.